David James Lennon
Chief Executive Officer at Whitehawk Therapeutics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Whitehawk Therapeutics Inc., 3 years.
Chief executive roles
Weak · grade F
Out of 100, from shareholder return, dividends, growth and acquisitions.
Partial: only 20% of the scoring weight is on file.
- Revenue growth 20%
- 0
-22.3% a year in revenue
20% of the scoring weight is on file. Figures cover December 2022 – December 2025.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Whitehawk Therapeutics Inc. June 11, 202582.2%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 14, 2026 | Whitehawk Therapeutics Inc. | Grant or award | +51,021 | $3.92 | $200,002 |
| Apr 9, 2026 | Whitehawk Therapeutics Inc. | Open-market sale | −14,500 | $3.38 | $49,010 |
| Apr 8, 2026 | Whitehawk Therapeutics Inc. | Open-market sale | −63,945 | $3.40 | $217,413 |
| Apr 7, 2026 | Whitehawk Therapeutics Inc. | Open-market sale | −94,087 | $3.43 | $322,718 |
| Apr 6, 2026 | Whitehawk Therapeutics Inc. | Open-market sale | −102,395 | $3.51 | $359,406 |
| Apr 2, 2026 | Whitehawk Therapeutics Inc. | Open-market sale | −26,858 | $3.48 | $93,466 |
| Apr 1, 2026 | Whitehawk Therapeutics Inc. | Option exercise | +775,828 | — | — |
| Mar 2, 2026 | Whitehawk Therapeutics Inc. | Open-market sale | −5,100 | $3.31 | $16,881 |
| Mar 1, 2026 | Whitehawk Therapeutics Inc. | Option exercise | +16,250 | — | — |
| Mar 3, 2025 | Whitehawk Therapeutics Inc. | Open-market sale | −5,690 | $2.35 | $13,372 |
| Mar 1, 2025 | Whitehawk Therapeutics Inc. | Option exercise | +16,250 | — | — |
| Oct 3, 2024 | Whitehawk Therapeutics Inc. | Open-market sale | −9,689 | $1.94 | $18,797 |
| Oct 2, 2024 | Whitehawk Therapeutics Inc. | Option exercise | +32,558 | — | — |
Questions about David James Lennon
What boards is David James Lennon on?
David James Lennon sits on the board of Whitehawk Therapeutics Inc.
What company is David James Lennon the CEO of?
David James Lennon has been Chief Executive Officer of Whitehawk Therapeutics Inc. since October 2023.
How long has David James Lennon served on boards?
Our records show at least 3 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.